Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors
NCT03443622
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Another study has been started in other country.
Conditions
Refractory Solid Tumor
Interventions
DRUG:
SC-43 Oral Solution
Sponsor
SupremeCure Pharma Inc.